Deal worth $112m
Jordan-based Hikma Pharmaceuticals has signed a $112m agreement to acquire US-based Baxter Healthcare Corporation’s US generic injectables business. The multi source injectables business comprises a comprehensive and complementary portfolio of 41 products in over 150 dosage strengths and forms across 23 therapeutic areas.
You might also like...
Iraq signs deal to develop the Akkas gas field
25 April 2024
Emaar appoints beachfront project contractor
25 April 2024
Acwa Power signs $356m Barka extension
25 April 2024
AD Ports secures Angola port concession agreement
25 April 2024
A MEED Subscription...
Subscribe or upgrade your current MEED.com package to support your strategic planning with the MENA region’s best source of business information. Proceed to our online shop below to find out more about the features in each package.